Dieter Weichenhan

12PUBLICATIONS
125CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Environmental epidemiologyHaematological tumoursAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Oct 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.

Yu-Yu Lin, Kersten Breuer, Dieter Weichenhan

|May 30, 2025
DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape.

Stephanie Gehrs, Zuguang Gu, Joschka Hey

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Aug 09, 2024
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).

Dieter Weichenhan, Anna Riedel, Etienne Sollier

|Apr 08, 2024
ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response.

Ali Bakr, Giuditta Della Corte, Olivera Veselinov

Pageof 2

Frequent Collaborators

11 joint publications

Christoph Plass

7 joint publications

Pavlo Lutsik

4 joint publications

Joschka Hey

3 joint publications

Matthias Schlesner